Recombinant human ARMC2 protein; Source: E. coli derived, PET30a; Tag: 6*His; Domain: 510-860 aa of BC030603
Conjugate
Unconjugated
Applications
Application Notes
WB: 1:500-1:3000 IF-FRO: 1:50-1:500
General Notes
This product (Catalog No. DPABH-20183) is a rabbit-derived polyclonal antibody raised against human ARMC2, targeting the amino acid region 510–860 of the protein. This antibody exhibits cross-reactivity with Human ARMC2 from mouse and rat. It has been affinity purified by Protein A. The ARMC2 protein (Armadillo Repeat Containing 2) is an evolutionarily conserved axonemal-related protein that plays a crucial role in the structure and function of cilia and flagella. It interacts with the kinesin-2 complex through its unique Armadillo repeat domain and acts as an adapter for the flagellar transport (IFT) process, responsible for transporting specific cargoes (such as the precursor proteins necessary for the construction of flagellar axons) from the cell body to the flagellar tip, which is essential for the assembly, maintenance, and signal transduction functions of the flagella. Its dysfunction is directly related to abnormal sperm flagellar morphology and movement disorders. DPABH-20183 is suitable for use in Western blot (WB) (1:500–1:3,000), IF-FRO (1:50–1:500) applications. DPABH-20183 is supplied as a liquid formulation in PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
My Review for Rabbit Anti-Human ARMC2 (a.a. 510-860) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.